Lv5
900 积分 2023-08-27 加入
Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma
11天前
已完结
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
1个月前
已完结
Childhood Liver Cancer Treatment (PDQ®): Health Professional Version
2个月前
已关闭
N6 -Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
3个月前
已完结
Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract Cancers
7个月前
已完结
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)
7个月前
已完结
皖公网安备34019202002308